CR
BMY icon

Cooperatieve Rabobank’s Bristol-Myers Squibb BMY Stock Holding History

Cooperatieve Rabobank’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-102,544
Closed -$5.25M – 37
2014
Q3 		$5.25M Buy
+102,544
New +$5.12M 6.54% 4

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $677M AUM 27.58% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cooperatieve Rabobank's BMY Position: Q4 2014 in Review

Cooperatieve Rabobank sold out of Bristol-Myers Squibb (BMY) in Q4 2014, closing a stake of 102,544 shares — an estimated $5.25M sold.

Cooperatieve Rabobank first reported a position in BMY in Q3 2014 and held it in 1 quarter. The position peaked at $5.25M in Q3 2014. 1,409 funds tracked by Wall St. Rank hold BMY as of Q4 2014.

  • Cooperatieve Rabobank reported no remaining Bristol-Myers Squibb position as of Q4 2014 after selling out during the quarter.
  • Cooperatieve Rabobank sold 102,544 Bristol-Myers Squibb shares in Q4 2014, an estimated $5.25M.
  • Cooperatieve Rabobank first reported a position in Bristol-Myers Squibb in Q3 2014 and held it in 1 quarter.
  • Cooperatieve Rabobank's Bristol-Myers Squibb position peaked at $5.25M in Q3 2014.
  • 1,409 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2014.

Based on Cooperatieve Rabobank's 13F filing for Q4 2014, filed 6 Feb 2015.